肌萎缩侧索硬化中无创通气使用的差异
研究基于Pooled Resource Open-Access ALS Clinical Trials数据库,分析1784例ALS患者中无创通气(NIV)的使用情况及预测因素。结果显示NIV使用率低于预期,FVC%≤50%时仅52.5%报告使用NIV;低FVC%、呼吸困难、端坐呼吸、较低球部和粗大运动子评分及男性是NIV启动的独立预测因素。
要点
- ALS患者中NIV使用率低于预期,FVC%≤50%时仅52.5%使用NIV。
- 低FVC%、呼吸困难、端坐呼吸、较低ALSFRS-R子评分及男性预测NIV启动。
- 无呼吸道症状和女性性别可能是NIV使用的障碍。
核心结论
- 在该ALS队列中NIV使用率低于预期,无呼吸道症状和女性性别可能是NIV使用的障碍。
研究设计与样本
- 基于Pooled Resource Open-Access ALS Clinical Trials数据库的队列研究,纳入1784例ALS患者,共8417次同步ALSFRS-R和FVC%测量。
主要发现
- 604例(33.9%)使用NIV;FVC%≤50%的918次 encounter 中482次(52.5%)报告NIV。
- NIV启动的独立预测因素包括FVC%每下降10%(HR 1.27,95%CI 1.17-1.37)、呼吸困难(HR 2.62,95%CI 1.87-3.69)、端坐呼吸(HR 4.09,95%CI 3.02-5.55)、ALSFRS-R球部子评分每降低1分(HR 1.09,95%CI 1.03-1.14)和粗大运动子评分每降低1分(HR 1.13,95%CI 1.07-1.20)及男性(HR 1.73,95%CI 1.31-2.28)。
- 调整其他变量后,球部起病对NIV时间无显著影响(HR 0.72,95%CI 0.47-1.08)。
- 发现NIV使用存在相当大的无法解释的变异。
临床怎么用
- 临床中应关注无呼吸道症状的ALS患者和女性患者,评估NIV启动障碍。
局限性
- NIV状态基于ALSFRS-R第12题的回答确定,可能存在漏报或误分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We sought to examine prevalence and predictors of noninvasive ventilation (NIV) in a composite cohort of patients with amyotrophic lateral sclerosis (ALS) followed in a clinical trials setting (Pooled Resource Open-Access ALS Clinical Trials database). METHODS: NIV initiation and status were ascertained from response to question 12 of the revised ALS Functional Rating Scale (ALSFRS-R). Factors affecting NIV use in patients with forced vital capacity (FVC) ≤50% of predicted were examined. Predictors of NIV were evaluated by Cox proportional hazard models and generalized linear mixed models. RESULTS: Among 1,784 patients with 8,417 simultaneous ALSFRS-R and FVC% measures, NIV was used by 604 (33.9%). Of 918 encounters when FVC% ≤50%, NIV was reported in 482 (52.5%). Independent predictors of NIV initiation were lower FVC% (hazard ratio [HR] 1.27, 95% confidence interval [CI] 1.17-1.37 for 10% drop), dyspnea (HR 2.62, 95% CI 1.87-3.69), orthopnea (HR 4.09, 95% CI 3.02-5.55), lower bulbar and gross motor subscores of ALSFRS-R (HRs 1.09 [95% CI 1.03-1.14] and 1.13 [95% CI 1.07-1.20], respectively, per point), and male sex (HR 1.73, 95% CI 1.31-2.28). Adjusted for other variables, bulbar onset did not significantly influence time to NIV (HR 0.72, 95% CI 0.47-1.08). Considerable unexplained variability in NIV use was found. CONCLUSION: NIV use was lower than expected in this ALS cohort that was likely to be optimally managed. Absence of respiratory symptoms and female sex may be barriers to NIV use. Prospective exploration of factors affecting adoption of NIV may help bridge this gap and improve care in ALS.
引用
- Thakore NJ, Lapin BR, Pioro EP, et al. Variation in noninvasive ventilation use in amyotrophic lateral sclerosis. Neurology. 2019. PMID: 31182506. doi:10.1212/WNL.0000000000007776
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。